CLARIANE SE (CLARI.PA) Stock Fundamental Analysis
Europe - EPA:CLARI - FR0010386334 - Common Stock
4.182 EUR
-0.05 (-1.18%)
CLARI gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 31 industry peers in the Health Care Providers & Services industry. CLARI has a bad profitability rating. Also its financial health evaluation is rather negative. CLARI has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year CLARI has reported negative net income.
CLARI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CLARI reported negative net income in multiple years.
Each year in the past 5 years CLARI had a positive operating cash flow.
1.2 Ratios
The Return On Assets of CLARI (-0.43%) is worse than 83.87% of its industry peers.
CLARI has a worse Return On Equity (-1.71%) than 83.87% of its industry peers.
CLARI's Return On Invested Capital of 1.63% is on the low side compared to the rest of the industry. CLARI is outperformed by 83.87% of its industry peers.
CLARI had an Average Return On Invested Capital over the past 3 years of 1.96%. This is below the industry average of 6.26%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.43% | ||
| ROE | -1.71% | ||
| ROIC | 1.63% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
1.3 Margins
CLARI has a Operating Margin (4.80%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CLARI has declined.
CLARI's Gross Margin of 91.90% is amongst the best of the industry. CLARI outperforms 96.77% of its industry peers.
In the last couple of years the Gross Margin of CLARI has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.8% | ||
| PM (TTM) | N/A | ||
| GM | 91.9% |
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CLARI is destroying value.
The number of shares outstanding for CLARI has been increased compared to 1 year ago.
Compared to 5 years ago, CLARI has more shares outstanding
CLARI has a better debt/assets ratio than last year.
2.2 Solvency
CLARI has an Altman-Z score of 0.63. This is a bad value and indicates that CLARI is not financially healthy and even has some risk of bankruptcy.
CLARI has a worse Altman-Z score (0.63) than 74.19% of its industry peers.
CLARI has a debt to FCF ratio of 13.25. This is a negative value and a sign of low solvency as CLARI would need 13.25 years to pay back of all of its debts.
CLARI has a Debt to FCF ratio (13.25) which is in line with its industry peers.
CLARI has a Debt/Equity ratio of 1.90. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.90, CLARI is not doing good in the industry: 74.19% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.9 | ||
| Debt/FCF | 13.25 | ||
| Altman-Z | 0.63 |
ROIC/WACC0.41
WACC3.92%
2.3 Liquidity
A Current Ratio of 0.67 indicates that CLARI may have some problems paying its short term obligations.
CLARI's Current ratio of 0.67 is on the low side compared to the rest of the industry. CLARI is outperformed by 80.65% of its industry peers.
CLARI has a Quick Ratio of 0.67. This is a bad value and indicates that CLARI is not financially healthy enough and could expect problems in meeting its short term obligations.
CLARI has a Quick ratio of 0.65. This is in the lower half of the industry: CLARI underperforms 64.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.65 |
3. Growth
3.1 Past
CLARI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.49%, which is quite impressive.
CLARI shows a small growth in Revenue. In the last year, the Revenue has grown by 2.70%.
The Revenue has been growing slightly by 7.89% on average over the past years.
EPS 1Y (TTM)84.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%
3.2 Future
The Earnings Per Share is expected to grow by 39.56% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 4.04% on average over the next years.
EPS Next Y170.47%
EPS Next 2Y86.53%
EPS Next 3Y58.66%
EPS Next 5Y39.56%
Revenue Next Year2.57%
Revenue Next 2Y3.2%
Revenue Next 3Y3.58%
Revenue Next 5Y4.04%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CLARI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 11.55, which indicates a very decent valuation of CLARI.
Based on the Price/Forward Earnings ratio, CLARI is valued a bit cheaper than 61.29% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CLARI to the average of the S&P500 Index (23.23), we can say CLARI is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.55 |
4.2 Price Multiples
CLARI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CLARI is cheaper than 61.29% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CLARI is valued cheaper than 93.55% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.41 | ||
| EV/EBITDA | 8.58 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLARI's earnings are expected to grow with 58.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.53%
EPS Next 3Y58.66%
5. Dividend
5.1 Amount
CLARI has a Yearly Dividend Yield of 10.64%, which is a nice return.
Compared to an average industry Dividend Yield of 2.52, CLARI pays a better dividend. On top of this CLARI pays more dividend than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, CLARI pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
5.2 History
The dividend of CLARI decreases each year by -7.26%.
Dividend Growth(5Y)-7.26%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CLARI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-110.43%
EPS Next 2Y86.53%
EPS Next 3Y58.66%
EPA:CLARI (10/22/2025, 5:29:59 PM)
4.182
-0.05 (-1.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.41%
Inst Owner ChangeN/A
Ins Owners5.63%
Ins Owner ChangeN/A
Market Cap1.49B
Revenue(TTM)5.31B
Net Income(TTM)-61380000
Analysts77.14
Price Target4.79 (14.54%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 10.64% |
Yearly Dividend0.19
Dividend Growth(5Y)-7.26%
DP-110.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)43.04%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)10.2%
EPS NY rev (3m)23.16%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 11.55 | ||
| P/S | 0.28 | ||
| P/FCF | 2.41 | ||
| P/OCF | 1.69 | ||
| P/B | 0.42 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.58 |
EPS(TTM)-0.17
EYN/A
EPS(NY)0.36
Fwd EY8.66%
FCF(TTM)1.73
FCFY41.42%
OCF(TTM)2.47
OCFY59.17%
SpS14.88
BVpS10.05
TBVpS-5.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.43% | ||
| ROE | -1.71% | ||
| ROCE | 2.21% | ||
| ROIC | 1.63% | ||
| ROICexc | 1.74% | ||
| ROICexgc | 3.53% | ||
| OM | 4.8% | ||
| PM (TTM) | N/A | ||
| GM | 91.9% | ||
| FCFM | 11.64% |
ROA(3y)-0.31%
ROA(5y)0%
ROE(3y)-1.27%
ROE(5y)0.01%
ROIC(3y)1.96%
ROIC(5y)2.04%
ROICexc(3y)2.07%
ROICexc(5y)2.22%
ROICexgc(3y)4.16%
ROICexgc(5y)4.53%
ROCE(3y)2.66%
ROCE(5y)2.78%
ROICexgc growth 3Y-9.02%
ROICexgc growth 5Y-8.45%
ROICexc growth 3Y-9.61%
ROICexc growth 5Y-8.51%
OM growth 3Y-16.28%
OM growth 5Y-11.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.3%
GM growth 5Y-0.14%
F-Score6
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.9 | ||
| Debt/FCF | 13.25 | ||
| Debt/EBITDA | 6.54 | ||
| Cap/Depr | 33.63% | ||
| Cap/Sales | 4.99% | ||
| Interest Coverage | 0.83 | ||
| Cash Conversion | 84.71% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.67 | ||
| Quick Ratio | 0.65 | ||
| Altman-Z | 0.63 |
F-Score6
WACC3.92%
ROIC/WACC0.41
Cap/Depr(3y)69.7%
Cap/Depr(5y)78.91%
Cap/Sales(3y)9.85%
Cap/Sales(5y)11.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
EPS Next Y170.47%
EPS Next 2Y86.53%
EPS Next 3Y58.66%
EPS Next 5Y39.56%
Revenue 1Y (TTM)2.7%
Revenue growth 3Y8.48%
Revenue growth 5Y7.89%
Sales Q2Q%1.05%
Revenue Next Year2.57%
Revenue Next 2Y3.2%
Revenue Next 3Y3.58%
Revenue Next 5Y4.04%
EBIT growth 1Y-22.25%
EBIT growth 3Y-9.18%
EBIT growth 5Y-4.33%
EBIT Next Year302.5%
EBIT Next 3Y65.72%
EBIT Next 5Y38.3%
FCF growth 1Y267.6%
FCF growth 3Y23.92%
FCF growth 5Y6.15%
OCF growth 1Y11.15%
OCF growth 3Y2.33%
OCF growth 5Y3.29%